Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be
associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical …

Carcinoid tumors are rare, slow-growing neuroendocrine neoplasms that often are indolent
and may not become clinically apparent until there has been metastatic spread or evidence …

Background: Neuroendocrine tumours (NETS) are classified by site of origin, with lung being
the second most common primary site after the gastrointestinal tract. Lung nets are rare and …

Previous work in Arabidopsis showed that after an ancient tetraploidy event, genes were
preferentially removed from one of the two homeologs, a process known as fractionation …

Neuroendocrine tumors comprise a broad family of tumors, the most common of which are
carcinoid and pancreatic neuroendocrine tumors. The NCCN Neuroendocrine Tumors …

Abstract Purpose 177Lu-Dotatate is an emerging treatment modality for patients with
unresectable or metastatic well-differentiated NETs. This study examines survival predictors …

OBJECTIVE Carcinoid cancer patients often have elevated levels of serotonin or its
precursor 5-hydroxytryptophan. Normally, serotonin synthesis accounts for a small fraction of …

In most cases gastro-enteropancreatic neuroendocrine tumors grow slowly. Interferon-α and
somatostatin analogs have shown symptomatic, biochemical, and, in a minority of cases …

Objectives: Although rare, carcinoid tumor of the appendix is the most common neoplasm of
the gastrointestinal tract in children and adolescents. It is usually an incidental finding after a …

Hepatic artery embolization (HAE) has been utilized for treatment of advanced hepatic
carcinoid metastases, with promising symptom palliation and tumor control. Our institution …